Floatz logo

Azithromycin

Obesity

University of OklahomaSmall moleculePhase 2Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
59/ 100

Competitive context

574 Active assets in the Obesity cohort.

Asset / SponsorPhaseRating
vi-0521
VIVUS LLC
Phase 4BBB
asc30
Ascletis Pharma (China) Co., Limited
Phase 2BBB
Tirzepatide
LABORATORIOS INDUFAR
Phase 4BBB
Phentermine
Russell McCulloh, MD
Phase 4BBB
Deoxycholic Acid
University of California, San Diego
Phase 4BBB

View all 50 →

Same molecule, other indications

Azithromycin is also rated in:

bronchiectasisDormant
BBB
Indicative ·
73 / 100
View asset →
cystic fibrosisDormant
BBB
Indicative ·
72 / 100
View asset →
dry eye syndromeDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →